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The assembly of the tegument of herpes simplex virus type 1 (HSV-1) is a complex process that involves a number of events at various sites
within virus-infected cells. Our studies focused on determining whether tegument proteins, VP1/2 and UL37, are added to capsids located within
the nucleus. Capsids were isolated from the nuclear fraction of HSV-1-infected cells and purified by rate-zonal centrifugation to separate B capsids
(containing the scaffold proteins and no viral DNA) and C capsids (containing DNA and no scaffold proteins). Western blot analyses of these
capsids indicated that VP1/2 associated primarily with C capsids and UL37 associated with B and C capsids. The results demonstrate that at least
two of the tegument proteins of HSV-1 are associated with capsids isolated from the nuclear fraction, and these capsid–tegument protein
interactions may represent initial events of the tegumentation process.
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Virions of herpes simplex virus type 1 (HSV-1) have three
morphologically distinct structures: an icosahedral capsid that
encloses the genome, a proteinaceous tegument layer surround-
ing the capsid, and a host-derived lipid envelope containing
viral glycoproteins and other membrane proteins (Roizman and
Sears, 2001). Capsid assembly occurs in the nucleus yielding
procapsids, as well as A, B, and C capsids, which can be
separated in density gradients (Gibson and Roizman, 1972;
Newcomb et al., 1996; Perdue et al., 1976). B capsids contain
the major capsid protein VP5, triplex proteins VP19C and
VP23, the minor capsid protein VP26, viral protease VP24, and
the scaffold proteins VP22a and VP21 (Newcomb and Brown,
1991; Roizman and Sears, 2001). Scaffold proteins are released
from the capsid as the viral genome enters through the UL6
portal complex to form the mature C capsid that becomes the
nucleocapsid of the mature virion (Newcomb et al., 2001). A
capsids are empty and contain no scaffold proteins or viral⁎ Corresponding author.
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(Perdue et al., 1976; Roizman and Sears, 2001).
Mature capsids exit the nucleus through an envelopment–
deenvelopment process. They acquire a temporary envelope by
budding into the inner nuclear membrane and subsequently lose
this envelope upon fusion with the outer nuclear membrane and
translocation into the cytoplasm (reviewed in Mettenleiter,
2002). The UL31 and UL34 gene products rearrange the nuclear
lamina and are necessary for the efficient egress of capsids from
the nucleus (Chang et al., 1997; Reynolds et al., 2001, 2004;
Roller et al., 2000 and reviewed in Mettenleiter, 2002).
Although the events of capsid assembly and DNA packaging
have been extensively studied, the molecular mechanisms
associated with the assembly of the tegument have been
described in limited detail. The addition of tegument onto
capsids could occur within the nucleus, as the capsid traverses
the inner and outer nuclear membranes, within the cytoplasm,
and finally as the capsid acquires its envelope from vesicles
derived from the trans-Golgi network (Mettenleiter, 2002;
Roizman and Sears, 2001). Immunoelectron microscopy studies
have shown the association of the tegument protein VP16 with
primary enveloped virions located within the perinuclear space
(Naldinho-Souto et al., 2006). Recent studies have suggested
Fig. 1. Analysis of the purity of the nuclear fraction obtained from HSV-1-
infected cells. Approximately 2×106 Vero cells were infected with HSV-1 at a
MOI of 10 pfu/cell. At 15 h after infection, the cells were harvested and
separated into the cytoplasmic and nuclear fractions as described in Materials
and methods. The proteins of the nuclear and cytoplasmic fractions were
resolved by SDS–PAGE followed by Western blot analysis simultaneously
using antibodies to the nuclear marker lamin B1 (70 kDa) and the endoplasmic
reticulum marker calnexin (90 kDa) to assay the same nitrocellulose blot.
317M.A. Bucks et al. / Virology 361 (2007) 316–324that HSV-1 envelopment of capsids may follow several diverse
pathways (Leuzinger et al., 2005).
Studies described within this report were focused on
determining whether specific tegument proteins are associated
with capsids isolated from the nuclear fraction of HSV-1-
infected cells. The two tegument proteins included within these
studies are VP1/2 and UL37. VP1/2 is a 270-kDa protein
encoded by the UL36 gene of HSV-1 (Heine et al., 1974;
Honess and Roizman, 1973; Marsden et al., 1978; McNabb and
Courtney, 1992a; Morse et al., 1978; Spear and Roizman,
1972). Previous studies have suggested that approximately
150 molecules of VP1/2 are present in each virion and that
VP1/2 is tightly associated with capsids (Heine et al., 1974;
McNabb and Courtney, 1992b; Roizman and Furlong, 1974).
VP1/2 is localized to both the cytoplasm and nucleus of virus-
infected cells (McNabb and Courtney, 1992b; Morrison et al.,
1998). VP1/2 is an essential viral protein with apparent
functions during early and late times after infection. The
phenotype of a mutant virus (tsB7) containing a temperature-
sensitive mutation in the UL36 gene suggests that VP1/2 is
involved in the release of the viral genome from capsids during
the initial events of virus infection (Batterson et al., 1983).
Immunoelectron microscopy studies have suggested that VP1/2
and UL37 remain associated with the capsid until it docks at the
nuclear pore (Granzow et al., 2005). Another mutant virus,
KΔUL36, encoding only the amino terminal 361 amino acids
residues of the VP1/2 protein, results in an accumulation of
DNA-containing capsids in the cytoplasm that lack the major
tegument proteins and an envelope (Desai, 2000). Furthermore,
studies have shown that the pseudorabies virus VP1/2
homologue is necessary for microtubule-based capsid transport
in the cytoplasm (Luxton et al., 2006). In addition, recent
studies have shown that the cleaved amino terminal 500 amino
acids of VP1/2 has deubiquitinating activity that is conserved
among homologues of the herpesvirus family (Kattenhorn et al.,
2005; Schlieker et al., 2005).
The 120-kDa protein encoded by the UL37 gene is
phosphorylated (Albright and Jenkins, 1993; McLauchlan
et al., 1994; Schmitz et al., 1995) and is found in both the
cytoplasm and nucleus of virus-infected cells (Schmitz et al.,
1995). A null mutant of UL37 (KΔUL37) results in an
accumulation of unenveloped capsids forming aggregates
along the inner nuclear membrane and in the cytoplasm
suggesting that UL37 plays an essential role in the virion
assembly process (Desai et al., 2001). The UL37, as well as the
UL36 gene product, are conserved among all subfamilies of
Herpesviridae (Mettenleiter, 2002). The pseudorabies virus
homologues of the HSV-1 VP1/2 and UL37 proteins have been
shown to physically interact (Klupp et al., 2002). Similar
findings were recently reported for HSV-1 VP1/2 and UL37
(Vittone et al., 2005).
The accumulation of capsids within or near the nucleus for
the UL37-null mutant KΔUL37 suggested the possibility that
this tegument protein and its binding partner, VP1/2, are added
to capsids in the nucleus. In addition, the strong association of
VP1/2 with capsids suggested that VP1/2 may be one of the
innermost tegument proteins of the virus. Using cell fraction-ation and density gradient analyses, we found that VP1/2 and
UL37 are associated with capsids purified from the nucleus.
Moreover, it appears that VP1/2 associates predominantly with
C capsids as compared to B capsids. These results suggest that
the addition of VP1/2 and UL37 may represent an initial
tegumentation event in the assembly of HSV-1 virions.
Results
Purity of isolated nuclear fractions
Throughout these studies, capsids from the nuclear fraction
of virus-infected cells were used; therefore, it was essential to
demonstrate that the nuclear fractions were free of components
from the cytoplasmic fraction. The nuclear and cytoplasmic
fractions from virus-infected cells were harvested at 15 h after
infection and analyzed by Western blotting for two marker
proteins of the cytoplasm and nucleus, calnexin and lamin B1,
respectively (Fig. 1). The blot was probed simultaneously with
antibodies to calnexin and lamin B1. Repeated analyses showed
that nuclear fractions were free of detectable levels of the
endoplasmic reticulum protein, calnexin, and the cytoplasmic
fraction did not contain detectable levels of lamin B1.
Purity of intranuclear capsids
Since the focus of this study is on capsids isolated from the
nuclear fraction, it was important to demonstrate that this capsid
preparation was free of capsids associated with the cytoplasmic
fraction. Vero cells were infected with HSV-1 KOS, harvested at
15 h post-infection (pi) and the cells were resuspended in 1.0%
NP40 lysis buffer. This cell preparation was then mixed with the
cytoplasmic fraction from HSV-1 K26GFP virus-infected cells
harvested at 15 h pi. All capsids within the K26GFP
cytoplasmic fraction contained the VP26–GFP chimeric
protein. Our goal was to determine if capsids obtained from
Fig. 2. Analysis of the purity of the nuclear capsid preparation. (A) Approximately 1.5×108 HSV-1 KOS-infected Vero cells were harvested at 15 h pi, resuspended in
1% NP40 lysis buffer and then mixed with the cytoplasmic fraction from approximately 1.3×108 Vero cells infected with HSV-1 K26GFP virus. This mixture was
incubated on ice for 30 min and the nuclear fraction was then purified as described in Materials and methods. Capsids from the nuclear fraction were purified and
separated on a 20–50% linear sucrose gradient following rate-zonal centrifugation. 0.5 ml fractions were collected from the bottom of the tube. The proteins within
each fraction were precipitated with 10% TCA, separated by SDS—PAGE followed byWestern blot analysis. The blot was probed sequentially with antibodies to GFP
and the major capsid protein VP5. K26GFP lysate (far right) shown in all panels served as a positive control for the Western blots. (B) Western blot analysis of capsids
isolated from the cytoplasmic fraction from approximately 2.6×107 K26GFP-infected Vero cells purified and analyzed as described above. K26GFP lysate is shown in
the far right lanes as a control.
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cross-contaminated with the VP26–GFP capsids from the
K26GFP cytoplasmic fraction. After a 30-min incubation on ice
in 1.0% NP40 lysis buffer, the nuclei were purified following
the protocol described in Materials and methods. Capsids from
the purified nuclear fraction were resolved by rate-zonal
centrifugation as described in Materials and methods. Fractions
from the density gradient were analyzed by SDS–PAGE and
Western blotting with antisera to GFP and VP5 (Fig. 2). As
shown in Fig. 2A, VP5 was detected in fractions 11–15 of the
gradient, indicating the location of capsids within the gradient.
However, no GFP-containing capsids were detected in the
gradient fractions indicating that the cytoplasmic GFP-contain-
ing capsids were effectively removed during the purification of
the nuclear fraction. As a positive control, the VP26–GFPFig. 3. Rate-zonal centrifugation of HSV-1 capsids isolated from the nuclear fraction
the nuclear fraction of HSV-1-infected Vero cells harvested at 15 h after infecti
centrifugation. 0.5 ml fractions were collected from the bottom of the tube. The prot
PAGE followed by Western blot analysis using primary antibodies to specific tegum
antibody conjugated to horseradish peroxidase. Western blot analysis was done usin
VP22a (scaffold proteins), tegument proteins VP1/2 and UL37, and the DNA bindicapsids within the cytoplasmic fraction of K26GFP-infected
cells were also resolved on another gradient and GFP-contain-
ing capsids were readily detected in fractions 11–15 by Western
blotting (Fig. 2B). The amount of the cytoplasmic fraction used
to obtain the VP26–GFP capsids loaded onto the gradient in
Fig. 2B was approximately 1/5 the amount of lysate that was
mixed with the KOS-infected cells prior to the purification of
the nuclear fraction. In both preparations, the major capsid
protein VP5 was detected in fractions 11–15. As will be
presented below, it is within these fractions that most of the
VP1/2 or UL37 is detected with capsids isolated from the
nuclear fraction. The results from this experiment suggest that
the nuclear isolation protocol used in this study yields a
population of nuclear capsids that is not contaminated with
capsids from the cytoplasmic fraction.and analyzed for the presence of tegument proteins. Capsids were obtained from
on and separated on a 20–50% linear sucrose gradient following rate-zonal
eins within each fraction were precipitated with 10% TCA, separated by SDS–
ent proteins followed by the addition of the secondary anti-rabbit or anti-mouse
g antibodies to capsid proteins VP5 (the major capsid polypeptide) and VP21/
ng protein UL42.
Fig. 5. SDS–PAGE analysis of the cell lysates of Vero (VP23 non-
complementing) and C32 (VP23 complementing) cells infected with the HSV-
1 VP23-negative mutant virus, K23Z. The two cell lines were infected with the
K23Z virus at a MOI of 10 pfu/cell and harvested at 15 h after infection. The
whole cell lysates were resolved by SDS–PAGE followed by Western blot
analysis. The same blot was probed sequentially with antibodies to VP5, VP16,
and UL37.
319M.A. Bucks et al. / Virology 361 (2007) 316–324Tegument proteins VP1/2 and UL37 associate with capsids
isolated from the nuclear fraction
At 15 h after infection, HSV-1-infected Vero cells were
fractionated into cytoplasmic and nuclear fractions. Capsids
from the nuclear fraction were loaded onto a 20–50% (wt/wt)
linear sucrose gradient and resolved by rate-zonal centrifuga-
tion. Fractions were collected, precipitated with 10% trichloro-
acetic acid, and analyzed by SDS–polyacrylamide gel
electrophoresis and Western blotting. Blots were reacted with
five different antibodies (Fig. 3). To identify where capsids were
located within the gradient, an antibody specific for the major
capsid polypeptide, VP5, was used. Western blotting with anti-
VP5 serum showed that most capsids were in fractions 11–15.
Antibodies specific for VP1/2 and UL37 showed that these two
tegument proteins were also present in the capsid-containing
fractions. Scaffold proteins VP21 and VP22a are associated with
B capsids and not with DNA-containing C capsids (Roizman
and Sears, 2001). When the blot was reacted with an antibody
specific for scaffold proteins, the major reactivity was seen in
fraction 12 with fractions 11 and 13 also showing the presence of
some scaffold protein. In contrast, most of the VP1/2 reactivity
was detected in fraction 14 that contains high amounts of VP5
but little to no scaffold proteins. When the blot was reacted with
a monoclonal antibody specific for the HSV-1 nonstructural
DNA-binding protein UL42 (Gallo et al., 1988), no reactivity
was detected in fractions containing VP5. The results presented
above suggest that tegument proteins VP1/2 and UL37 are
associated with capsids isolated from the nuclear fraction of
virus-infected cells.
As a control for the specific binding of selected tegument
proteins to capsids isolated from the nucleus, two additional
tegument proteins were assayed, VP22 and UL11. VP22 is one
of the most abundant tegument proteins of purified HSV-1
virions (Heine et al., 1974). Depending on the time after
infection, VP22 is localized within the cytoplasm as well as the
nucleus of virus-infected cells (Morrison et al., 1998; Pomeranz
and Blaho, 1999). UL11 is a myristoylated tegument protein that
is localized primarily to the Golgi region (Bowzard et al., 2000;
MacLean et al., 1989). Capsids from the nuclear fraction were
isolated, purified and assayed by Western blotting as described
above. Antibody to VP5 was used to identify the location of theFig. 4. Rate-zonal centrifugation of HSV-1 capsids isolated from the nuclear fraction a
infection the capsids from the nuclear fraction were obtained, separated by rate-zona
sequentially using antibodies specific for the major capsid protein VP5 and tegumencapsids resolved by rate-zonal centrifugation. In addition,
antibody to the tegument protein UL37 was included as a
positive control. As shown in Fig. 4, density gradient fractions
demonstrating reactivity with antisera to VP5 and UL37 were
similar to that shown previously in Fig. 3. However, when the
blot was reacted with antisera specific for either VP22 or UL11,
no reactivity was detected. Western blot analysis of purified
extracellular virions showed strong reactivity with antisera to
VP22 and UL11 (data not shown). These results further support
the specificity of the detection of tegument proteins VP1/2 and
UL37 with capsids isolated from the nuclear fraction of HSV-1-
infected cells.
The detection of VP1/2 and UL37 in density gradients is capsid
dependent
To ascertain whether the co-sedimentation of VP1/2 and
UL37 with VP5 was due to their association with capsids, the
analysis was done in the absence of capsid formation. A mutant
virus (K23Z) defective in the synthesis of the VP23 triplex
protein was kindly provided by Dr. Prashant Desai. When this
mutant infects Vero cells, no capsids form due to the absence of
the UL18 gene, which encodes the VP23 triplex protein (Desai
et al., 1993). Vero cells and the VP23 complementing cell line
(C32) were infected with the K23Z virus and harvested at 15 h
after infection. Prior to cell fractionation, a sample of the total
cell lysate from K23Z virus-infected Vero and complementingnd analyzed for the presence of tegument proteins VP22 and UL11. At 15 h after
l centrifugation as described in the legend of Fig. 3. The same blot was probed
t proteins VP22, UL11, and UL37 (positive control).
Fig. 6. Rate-zonal centrifugation of capsids isolated from cells infected with the VP23-negative mutant (K23Z) and analysis for the presence of tegument proteins VP1/2
andUL37. Vero (non-complementing cell line) and C32 (complementing cell line expressingVP23) cells were infected with the VP23-negativemutant virus, K23Z, at a
MOI of 10 pfu/cell. At 15 h after infection the capsids from the nuclear fraction were obtained, separated by rate-zonal centrifugation, analyzed by SDS–PAGE followed
by Western blot analysis as described in the legend of Fig. 3. The same blot was probed sequentially for the presence of VP5 and tegument proteins VP1/2 and UL37.
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Western blotting for the presence of VP5, VP16 and UL37 (Fig.
5). In both cases, expression of VP5, VP16 and UL37 was
readily detected by immunoblotting. These same cell lysates
were fractionated, and capsids obtained from the nuclear fraction
were resolved on a density gradient, precipitated with TCA, and
analyzed by SDS–PAGE and Western blotting (Fig. 6). As
expected, capsids from the complementing C32 cells exhibited
VP5, VP1/2, and UL37 in similar fractions as seen in other
gradients presented above. Most of the detectable VP1/2 was inFig. 7. Rate-zonal centrifugation of 3H-thymidine-labeled capsids and analysis for the
fraction of HSV-1-infected Vero cells that were labeled with 10 μCi/ml of 3H-thym
centrifugation as described in the legend of Fig. 3. Prior to TCA precipitation of the pr
each fraction was determined by liquid scintillation analysis (panel A). Following T
Western blot analysis (panel B). The same blot was sequentially probed with antibo
(scaffold proteins) as described in the legend of Fig. 3.fraction 13, the same fraction where there was a strong reactivity
to anti-VP5. The detection of UL37 was also seen in similar
fractions as described for other gradients. In contrast, neither
VP5, VP1/2, nor UL37 was detectable in the region of the
gradient where capsids normally sediment when the nuclear
fraction from the nonpermissive Vero cells was analyzed.
Although VP5, VP1/2 and UL37 are present in the nucleus in the
absence of capsid formation, they are not readily detected in the
linear sucrose gradient in the absence of capsid formation. When
not associated with capsids, these proteins do not effectivelypresence of the tegument protein VP1/2. Capsids were obtained from the nuclear
idine from 3 to 15 h after infection. The capsids were separated by rate-zonal
oteins within each of the fractions, 50 μl was removed and 3H-thymidine CPM in
CA precipitation, the same fractions were resolved by SDS–PAGE followed by
dies to the tegument protein VP1/2 and capsid proteins VP5 and VP21/VP22a
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that precedes the linear sucrose gradient analysis. In some
experiments, small but detectable amounts of UL37 were
observed in fractions toward the bottom of the gradient
suggesting the formation of non-capsid associated complexes.
Overall, these results further support that VP1/2 and UL37
sediment in a capsid-dependent manner due to their association
with intranuclear capsids.
VP1/2 associates primarily with C capsids
The results shown in Fig. 3 suggest that the sucrose gradient
resolved capsids into two populations. Based on the reactivity
of the fractions with the anti-scaffold antibody, it appeared that
the slower sedimenting capsid population contained a prepon-
derance of B capsids. However, VP1/2 was predominantly
found with the faster sedimenting capsid population, a fraction
that showed no detectable reactivity with antiserum specific for
scaffold proteins and presumably contains mostly C capsids. To
confirm that the faster migrating band of capsids was indeed
composed of DNA-containing C capsids, Vero cells were
infected with wild-type HSV-1 and labeled with 3H-thymidine
from 3 to 15 h after infection. These cells were harvested,
fractionated into cytoplasmic and nuclear fractions, and capsids
isolated from the nuclear fraction were resolved by rate-zonal
centrifugation as described above. Each fraction was analyzed
for 3H-thymidine, precipitated with TCA, and analyzed by
SDS–PAGE and Western blotting (Fig. 7). A peak of 3H-
thymidine counts was detected in fraction 13 and immunoblot-
ting showed the presence of strong reactivity for the anti-VP5
and anti-VP1/2 sera within this fraction. In contrast, when these
same fractions were reacted with the anti-scaffold antibody,
essentially all reactivity was detected in fraction 11. These data
further confirm that density gradients were able to resolve
populations of B capsids and C capsids, and that the majority of
the detectable VP1/2 is associated with C capsids.
Discussion
To our knowledge, the results within this report are the first
to show that specific tegument proteins are added to capsids
prior to their exit from the nucleus. This is consistent with the
tight interaction of VP1/2 with virion capsids (McNabb and
Courtney, 1992b; Roizman and Furlong, 1974). In fact, Zhou et
al. suggested that VP1/2 may be an inner tegument protein
associated with pentons of the capsid based on the interpretation
of computer generated models from cryoelectron micrographs
of HSV-1 virus particles (Zhou et al., 1999). Recent observa-
tions by Desai using a VP1/2 mutant virus, KΔUL36, showed
that capsids synthesized in cells lacking the expression of VP1/2
were located within the cytoplasm; however, they lacked any of
the major tegument proteins and did not progress to the
envelopment stage of virus assembly (Desai, 2000). The
rationale for analysis of the presence of UL37 on capsids
within the nuclear fraction was supported by several observa-
tions. First, it was recently shown that the UL36 and UL37 gene
products of pseudorabies virus, as well as HSV-1, physicallyinteract (Klupp et al., 2002; Vittone et al., 2005). Second, other
studies have shown that viruses not expressing UL37 were not
enveloped and formed aggregates in the nucleus and cytoplasm
(Desai et al., 2001). From the above observations, it appears that
VP1/2 and UL37 may associate with capsids before subsequent
tegumentation and envelopment events can occur. Thus it is
possible that these two proteins are components of the “inner”
tegument region and may serve as a platform for the addition of
other tegument proteins to the capsid.
The UL36 and UL37 gene products are conserved among all
members of the herpesvirus subfamilies (Mettenleiter, 2002),
which may indicate their key role in the assembly process. In
addition, the studies of Desai (Desai, 2000; Desai et al., 2001)
suggest that these two proteins may be important for targeting
the capsid to the proper maturation pathway for the addition of
other tegument proteins and envelopment. Whether the addition
of VP1/2 and UL37 to assembled capsids only occurs within the
nucleus cannot be determined from the studies described within
this report and is an aspect currently being addressed. Yeast
two-hybrid analyses have shown the interaction of VP1/2 with
the tegument proteins VP16 and UL37, and also demonstrated
the self-association of UL37 (Vittone et al., 2005). Further
understanding of these interactions may help to elucidate the
composition of the “inner tegument” region. Interestingly, the
Kaposi's sarcoma-associated herpesvirus homologue of VP1/2,
ORF64, is proposed to bind to the capsid at its N-terminus and
attach to the viral envelope at its C-terminus (Zhu et al., 2005).
An unexpected finding from our studies was that VP1/2 is
predominantly associated with C capsids as compared to B
capsids. Althoughmajor differences in conformation and protein
content of B vs. C capsids have not been suggested, subtle
differences have been reported (Beard et al., 2004; Goshima et
al., 2000; Ogasawara et al., 2001; Sheaffer et al., 2001; Thurlow
et al., 2005; Zhou et al., 1999). For example, studies have shown
that three- to four-fold greater amounts of UL25 are associated
with C capsids as compared to B capsids, suggesting that UL25
may function to seal the capsid portal after DNA packaging
(Ogasawara et al., 2001; Sheaffer et al., 2001). Cryoelectron
microscopic observations suggest that the channel within
pentons of B capsids appears open, in contrast the pentagonal
channel in C capsids appears closed (Zhou et al., 1999). The
selective binding of VP1/2 to C capsids suggests that either the
conformation or the selective presence of other capsid or
tegument proteins enhances the opportunity for the binding of
VP1/2. Currently, our results do not demonstrate if the binding of
UL37 is preferential to C or B capsids. Studies are currently in
progress to determine if there is a sequential order for the binding
of VP1/2 and UL37 to capsids.
Materials and methods
Cells and viruses
African green monkey kidney (Vero) cells (ATCC CCL-81)
were grown in Dulbecco's modified Eagles medium (DMEM)
supplemented with 5% fetal bovine serum (FBS), 2.25% sodium
bicarbonate, 25 mM HEPES buffer, glutamine (300 μg/ml),
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described previously (O'Regan et al., in press). Cells were
infected in the samemedium except the serum concentration was
reduced to 2.0%. HSV-1 KOS strain was used as the wild-type
virus (Smith, 1964). An HSV-1 mutant virus (designated K23Z)
with a defect in the synthesis of one of the capsid triplex proteins,
VP23, and the complementing cell line (designated C32) that
expresses this protein, were generously provided by Prashant
Desai (Johns Hopkins University) (Desai et al., 1993; Person and
Desai, 1998). The C32 complementing cell line was grown as
described above, with the addition of 1.0 mg/ml G148
(Geneticin; Calbiochem, San Diego, CA) (Person and Desai,
1998).
Antibodies
Rabbit polyclonal antibodies to VP1/2 (McNabb and Court-
ney, 1992b), VP5 (McNabb, unpublished data), VP22 (Loomis
et al., 2003) and UL11 (Loomis et al., 2003) have been described
previously. Rabbit polyclonal antibody to GFP was generated
against His-GFP antigen. Rabbit polyclonal antibody to VP16
was purchased from Clontech (Clontech, Mountain View, CA).
Mouse monoclonal antibodies were used to detect the HSV-1
DNA-binding protein encoded by the UL42 gene (Martin et al.,
1988) and the UL26 gene products (scaffold proteins) (MCA406;
Serotec, Washington, DC) (Newcomb et al., 1996). A rabbit
polyclonal antibody (designated 780) to the UL37 gene product
was generously provided by Frank Jenkins (University of
Pittsburgh) (Schmitz et al., 1995). Goat polyclonal antibodies to
calnexin and lamin B1 (Santa Cruz Biotechnology, Santa Cruz,
CA) were used to assess the purity of nuclear fractions.
Capsid isolation
Approximately 1.5×108 Vero cells grown in eighteen 100-
mm plates were infected with HSV-1 at a multiplicity of
infection (MOI) of 10 pfu/cell. At 15 h after infection, cells were
harvested by scraping, pelleted using low speed centrifugation
(225×g, 10min at 4 °C) andwashed in phosphate-buffered saline
(PBS). Cells were disrupted in NP40 lysis buffer (approximately
9×106 cells/ml) [0.15 M NaCl, 0.01 M Tris–HCl (pH 7.2),
0.002 M MgCl2, 1.0% NP-40 (IGEPAL CA-630; Sigma, St.
Louis, MO), 0.005 M DL-dithiothreitol, and 0.01% protease
inhibitor cocktail (Sigma)] (Gibson and Roizman, 1972;
McNabb and Courtney, 1992c). The nuclei were pelleted using
low speed centrifugation (225×g, 7 min at 4 °C), and the
supernatant was considered the cytoplasmic fraction. The
nuclear pellet was washed in NP40 lysis buffer and transferred
to a clean conical tube to reduce contaminating cytoplasmic
debris that might be stuck to the sides of the tubes. Capsids from
the nuclear fraction were isolated as previously described with
slight modifications (Sheaffer et al., 2000). The nuclear pellet
was resuspended in NP40 lysis buffer, lysed by three cycles of
freeze/thaw and then sonicated for three 1-min pulses. Cell
debris was cleared by centrifugation at 8000 rpm for 30 min at
4 °C in an SW41 rotor. The supernatant was treated with 100 U
DNase at 37 °C for 10 min and the capsids were pelleted througha 35% (wt/wt) sucrose cushion [prepared in TNE (500 mM
NaCl, 1 mM EDTA, 20 mM Tris, pH 7.6)] in a SW41 rotor
centrifuged at 24,500 rpm for 1 h at 4 °C. The pellet was
resuspended in TNE and sonicated three times at 10 s each. The
sample was layered onto a 20–50% (wt/wt) linear sucrose
gradient (prepared in TNE) and centrifuged at 24,500 rpm for 1 h
at 4 °C in an SW41 rotor. After centrifugation, 0.5-ml fractions
were collected from the bottom of the tube. Trichloroacetic acid
(TCA) was added to each fraction for a final concentration of
10% TCA and incubated at 4 °C for a minimum of 1 h.
Precipitated proteins were pelleted by centrifugation (14,000×g
for 15 min at room temperature), washed in 100% ethanol, dried
by centrifugation in a heat-vac for 5 min, resuspended in 2×
sample buffer [119 mM Tris–HCl, pH 6.8, 19% glycerol, 0.05%
bromophenol blue, 3.8% SDS, 9.5% β-ME, 0.5 M urea], boiled
for 5 min, and electrophoretically separated on a SDS–
polyacrylamide gel (PAGE). After transferring to nitrocellulose
membranes, proteins were detected by Western blot analysis
with primary antibodies to specific HSV-1 proteins, secondary
antibodies conjugated to horseradish peroxidase (Sigma), ECL
reagents (Amersham Biosciences, Piscataway, NJ), chemilumi-
nescence autoradiography and Kodak BioMax XAR film. For
sequential probing of the same nitrocellulose blot, membranes
were stripped in 60 mM Tris–HCl, pH 8.0, 2% SDS and 0.75%
β-ME at 56 °C for 37 min to remove bound antibodies.
Radiolabeling viral DNA
To radiolabel the viral DNA associated with C capsids,
approximately 1.5×108 Vero cells grown in eighteen 100-mm
plates were infected with HSV-1 at a MOI of 10 pfu/cell. At
3 h after infection, [methyl-3H]thymidine (specific activity of
79 Ci/mmol, 1.0 mCi/ml) (Perkin Elmer, Boston, MA) was
added to 5 plates at a concentration of 10 μCi/ml. At 15 h
after infection, infected cells were harvested and intranuclear
capsids were purified on a linear sucrose gradient as
described above. From each of the collected fractions, 50 μl
was removed and assayed for 3H-thymidine activity by liquid
scintillation analysis. The remainder of the 0.5 ml fractions
was TCA precipitated, resolved on an SDS–PAGE gel and
Western blotted for the presence of viral proteins.
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